While mature CML cells actively proliferate due to BCR–ABL1-dependent signaling, CML stem cells are able to avoid proliferation and maintain quiescence in an oncogene-independent fashion [9]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.